Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


Isla Mackenzie is Professor of Cardiovascular Medicine and Honorary Consultant Physician at the University of Dundee and Ninewells Hospital, Dundee, UK. She is the Deputy Director of the Medicines Monitoring Unit (MEMO Research) and Hypertension Research Centre (HRC), University of Dundee. Prof Mackenzie completed Clinical Pharmacology and Therapeutics specialist training in Cambridge. She currently leads clinical research studies in cardiovascular disease and drug safety and has an interest in the decentralisation of clinical trials. Prof Mackenzie sits on several trial steering committees and other national committees relating to clinical pharmacology, pharmaceutical medicine, medicine and hypertension. She leads a work package in the recently awarded Trials@Home project – a 5-year IMI project aiming to reshape clinical trials in Europe. Ongoing trials include ALL-HEART which is investigating whether the gout medicine allopurinol provides cardiovascular benefit and TIME which is testing whether it is better to take blood pressure lowering medicines in the morning or at night.

Forthcoming events

Richard Doll Seminar - Adventures in Digital Health Research: Alcohol, Coffee, and Arrhythmias

Tuesday, 03 September 2024, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, OldRoad Campus, University of Oxford, OX3 7LF